MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT
... ML, Hall WJ, Moss AJ: MADIT II Investigators. Inappropriate implantablecardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-1365. ...
... ML, Hall WJ, Moss AJ: MADIT II Investigators. Inappropriate implantablecardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-1365. ...
PATHOPHYSIOLOGY OF CARDIOVASCULAR SYSTEM
... Cerebral perfusion is adapted to the changing, activation-dependent oxygen demand of different brain regions via local redistribution of blood flow. 66. What does the Monroe-Kelly principle state? The volume of any intracranial compartment may only increase at the expense of the others, otherwise an ...
... Cerebral perfusion is adapted to the changing, activation-dependent oxygen demand of different brain regions via local redistribution of blood flow. 66. What does the Monroe-Kelly principle state? The volume of any intracranial compartment may only increase at the expense of the others, otherwise an ...
Tumor Necrosis Factor and Steroid Metabolism in Chronic
... The weight loss of patients with chronic heart failure has been recognized since earliest times (14), but the cause remains obscure. A variety of abnormalities of cytokines have been described (4,5) as has an increase in insulin resistance (15) and an elevation in catabolic steroids in untreated pat ...
... The weight loss of patients with chronic heart failure has been recognized since earliest times (14), but the cause remains obscure. A variety of abnormalities of cytokines have been described (4,5) as has an increase in insulin resistance (15) and an elevation in catabolic steroids in untreated pat ...
Correspondence - Circulation: Arrhythmia and Electrophysiology
... 6. Opthof T, Coronel R, Wilms-Schopman FJG, Plotnikov AN, Shlapakova IN, Danilo P, Rosen MR. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm. 2007;4:341–348. ...
... 6. Opthof T, Coronel R, Wilms-Schopman FJG, Plotnikov AN, Shlapakova IN, Danilo P, Rosen MR. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm. 2007;4:341–348. ...
Iodine-123 mIBG Imaging for Predicting the Development of Atrial
... LAD ⴝ left atrial dimension disease, or degenerative cerebral disease, LVEF ⴝ left ventricular ejection and patients who had a history of known fraction thrombus or vascular events were also SNS ⴝ sympathetic nervous excluded from this study. system All patients gave written informed consent before ...
... LAD ⴝ left atrial dimension disease, or degenerative cerebral disease, LVEF ⴝ left ventricular ejection and patients who had a history of known fraction thrombus or vascular events were also SNS ⴝ sympathetic nervous excluded from this study. system All patients gave written informed consent before ...
Chapter 19
... Chest pain onset, location, radiation, character, exertional or at rest, other s/sx, NTG Dyspnea exertional or at rest, positional, constant or intermittent, awakens at night (paroxysmal nocturnal dyspnea occurs with heart failure) Orthopnea # of pillows used when supine Cough duration, fr ...
... Chest pain onset, location, radiation, character, exertional or at rest, other s/sx, NTG Dyspnea exertional or at rest, positional, constant or intermittent, awakens at night (paroxysmal nocturnal dyspnea occurs with heart failure) Orthopnea # of pillows used when supine Cough duration, fr ...
Copeptin in patients with heart failure and preserved ejection
... Introduction: Underlying mechanisms of heart failure (HF) with preserved ejection fraction (HFPEF) remain unknown. We explored copeptin, a biomarker of the arginine vasopressin system, hypothesising that copeptin in HFPEF is elevated, associated with diastolic dysfunction and N-terminal pro-brain na ...
... Introduction: Underlying mechanisms of heart failure (HF) with preserved ejection fraction (HFPEF) remain unknown. We explored copeptin, a biomarker of the arginine vasopressin system, hypothesising that copeptin in HFPEF is elevated, associated with diastolic dysfunction and N-terminal pro-brain na ...
Heart failure
... Based on the ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult January 2006 ...
... Based on the ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult January 2006 ...
Prognostic Value of Extravascular Lung Water Assessed With
... the end of the standard two-dimensional echocardiogram as previously described.8 Briefly, the ultrasound scanning of the anterior and lateral chest was obtained on the right and left hemithoraxes, from the second to fourth (on the right side to the fifth) intercostal spaces and from the parasternal ...
... the end of the standard two-dimensional echocardiogram as previously described.8 Briefly, the ultrasound scanning of the anterior and lateral chest was obtained on the right and left hemithoraxes, from the second to fourth (on the right side to the fifth) intercostal spaces and from the parasternal ...
Full Text - Res Cardiovasc Med
... BAFTA Trial has shown that the use of aspirin in elderly patients does not reduce the risk of major bleedings, compared to oral anticoagulants, whereas a significantly higher number of TE events occurred (16). The increased risk of bleeding when multiple anticoagulants are administered is well known ...
... BAFTA Trial has shown that the use of aspirin in elderly patients does not reduce the risk of major bleedings, compared to oral anticoagulants, whereas a significantly higher number of TE events occurred (16). The increased risk of bleeding when multiple anticoagulants are administered is well known ...
Cardiotoxicity induced by tyrosine kinase inhibitors GEORGE S. ORPHANOS
... a prohormone of BNP secreted by cardiomyocytes in response to ventricular dilation or local wall stress and is considered a sensitive marker to detect left ventricular systolic dysfunction. Only one patient with normal pre-treatment NT-proBNP showed an increase above normal after three months and cl ...
... a prohormone of BNP secreted by cardiomyocytes in response to ventricular dilation or local wall stress and is considered a sensitive marker to detect left ventricular systolic dysfunction. Only one patient with normal pre-treatment NT-proBNP showed an increase above normal after three months and cl ...
Non-Cardiac Surgery for Adults with CHD
... as there is, in essence, a continuous column of blood from the aorta to the systemic capillaries, systemic veins, pulmonary capillaries, and finally the pulmonary veins. Normally 70% of the total blood volume is contained on the venous side of the circulation with the venous circulation having a cap ...
... as there is, in essence, a continuous column of blood from the aorta to the systemic capillaries, systemic veins, pulmonary capillaries, and finally the pulmonary veins. Normally 70% of the total blood volume is contained on the venous side of the circulation with the venous circulation having a cap ...
cardiovascular_fitness_teaching_outline_8
... evaluates the health of your heart by measuring its electrical activity. It determines if there is an irregular or dangerous heartbeat that can’t be detected with a stethoscope. ...
... evaluates the health of your heart by measuring its electrical activity. It determines if there is an irregular or dangerous heartbeat that can’t be detected with a stethoscope. ...
Summary Introduction
... with diuretics. Therefore, the issue of whether the mechanism of action of antihypertensive drugs might influence their clinical effect remains unresolved. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial offered a further opportunity to test this hypothesis by comparing the eff ...
... with diuretics. Therefore, the issue of whether the mechanism of action of antihypertensive drugs might influence their clinical effect remains unresolved. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial offered a further opportunity to test this hypothesis by comparing the eff ...
2013 HF Guidelines: Focus on Rehabilitation, Exercise and Surgical
... 2.In contrast to the chronic stable patient with heart failure, urgent directed culprit vessel angioplasty continues to be the revascularization modality of choice for patients with acute coronary syndrome complicated by heart failure. 3.In highly selected cases, patients with advanced heart failure ...
... 2.In contrast to the chronic stable patient with heart failure, urgent directed culprit vessel angioplasty continues to be the revascularization modality of choice for patients with acute coronary syndrome complicated by heart failure. 3.In highly selected cases, patients with advanced heart failure ...
Left atrial volume predicts adverse cardiac and cerebrovascular
... MACCE (a composite of stroke, sudden death, and congestive heart failure) in HCM patients with normal pump function. However, LA diameter, a standard measure used to assess LA size, was not associated with the risk of MACCE. A previous study reported that HCM patients have a 4-6-fold increased risk ...
... MACCE (a composite of stroke, sudden death, and congestive heart failure) in HCM patients with normal pump function. However, LA diameter, a standard measure used to assess LA size, was not associated with the risk of MACCE. A previous study reported that HCM patients have a 4-6-fold increased risk ...
The prevalence of the metabolic syndrome and its impact on the left
... LV dysfunction in a number of diseases. Reduced Sm velocities have been shown in patients with mutations of hypertrophic cardiomyopathy at the time of subclinical disease when cardiac hypertrophy is not present17. In asymptomatic patients with severe mitral regurgitation and normal LV ejection fract ...
... LV dysfunction in a number of diseases. Reduced Sm velocities have been shown in patients with mutations of hypertrophic cardiomyopathy at the time of subclinical disease when cardiac hypertrophy is not present17. In asymptomatic patients with severe mitral regurgitation and normal LV ejection fract ...
AHA/ASA Scientific Statement Recommendations
... • Aggressive treatment of worsening cardiac arrhythmias with appropriate medications and continued cardiac monitoring is recommended. (Class I, Level of Evidence C) • There are insufficient data to recommend a specific systolic or mean arterial blood pressure target. Blood pressure--lowering drugs m ...
... • Aggressive treatment of worsening cardiac arrhythmias with appropriate medications and continued cardiac monitoring is recommended. (Class I, Level of Evidence C) • There are insufficient data to recommend a specific systolic or mean arterial blood pressure target. Blood pressure--lowering drugs m ...
Behçet`s Disease and the Heart
... Behçet’s Disease and the Heart How is the heart affected by Behçet’s disease? As Behçet’s disease causes inflammation of blood vessels (vasculitis) and an increased tendency to blood clotting (thrombosis), it is reasonable to assume that the heart may sometimes be affected. Studies show that 7–46% o ...
... Behçet’s Disease and the Heart How is the heart affected by Behçet’s disease? As Behçet’s disease causes inflammation of blood vessels (vasculitis) and an increased tendency to blood clotting (thrombosis), it is reasonable to assume that the heart may sometimes be affected. Studies show that 7–46% o ...
Varespladib and Cardiovascular Events in Patients With an Acute
... studies.11 Initial studies demonstrated that varespladib reduced levels of sPLA2-IIA by more than 90%, in addition to lowering low-density lipoprotein cholesterol (LDL-C) and Creactive protein (CRP) in patients with stable coronary disease and ACS.12-14 The Vascular Inflammation Suppression to Treat ...
... studies.11 Initial studies demonstrated that varespladib reduced levels of sPLA2-IIA by more than 90%, in addition to lowering low-density lipoprotein cholesterol (LDL-C) and Creactive protein (CRP) in patients with stable coronary disease and ACS.12-14 The Vascular Inflammation Suppression to Treat ...
CardioRenal Interrelationship
... - Even minimal increases in serum creatinine after cardiac surgery is associated with increased ...
... - Even minimal increases in serum creatinine after cardiac surgery is associated with increased ...
Dronedarone in patients with congestive heart failure - MS
... The design and the primary results of the ATHENA trial have been previously published.3,5 In short, patients with paroxysmal or persistent AF and at least one additional risk factor for CV events including age ≥75 years or ,75 years with one or more of the following risk factors: hypertension, diabe ...
... The design and the primary results of the ATHENA trial have been previously published.3,5 In short, patients with paroxysmal or persistent AF and at least one additional risk factor for CV events including age ≥75 years or ,75 years with one or more of the following risk factors: hypertension, diabe ...
Chronic Valvular Disease in the Dog
... results in improved survival.7,8 ● Furosemide & pimobendan: Following publication of the QUEST study8 it appears optimal chronic management of patients with mitral regurgitation should include administration of these medications. ● ACE Inhibitors: It is widely believed by cardiologists that ACE inhi ...
... results in improved survival.7,8 ● Furosemide & pimobendan: Following publication of the QUEST study8 it appears optimal chronic management of patients with mitral regurgitation should include administration of these medications. ● ACE Inhibitors: It is widely believed by cardiologists that ACE inhi ...